Yesintek (ustekinumab-kfce)

Manufacturer:

Biocon Biologics

Route of Administration:

Intravenous, Subcutaneous

Site of Care:

Outpatient

Website:

phone:

Enrollment Forms:

Synergen Prescription Form

Patient Support Form

Approved Indication:

treatment of adults and pediatric patients 6 years and older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
treatment of active psoriatic arthritis in adults and pediatric patients 6 years and older
treatment of moderately-to-severely active Crohn’s disease in adults
treatment of moderately-to-severely active ulcerative colitis in adults

Conditions:

Crohn’s Disease
Plaque Psoriasis
Psoriatic Arthritis
Ulcerative Colitis

Therapeutic Area:

Dermatology
Gastroenterology
Rheumatology